Meet Catalyst BioCampus, the latest life science development in Holly Springs

RALEIGH – A new life sciences campus is underway in Holly Springs.

Catalyst BioCampus, which developers noted in a statement will be the first location in the Triangle to offer what is known as a “High-Performace Shell” to enable life science firms to accelerate production.

The planned facility will be ready made to enable current good manufacturing practices (cGMP) in biomanufactuing, according to the statement.  That includes primary mechanical, electrical, and building infrastructure features that together could enable companies to accelerate their timeline to production of pharmaceutical therapies by as much as 15 months.

“Catalyst BioCampus is a major new addition to North Carolina’s strong biomanufacturing community, providing a uniquely flexible, scalable, and rapidly deployable solution for companies,” said Bill Bullock, SVP of Economic Development with North Carolina Biotechnology Center.

CBRE|Raleigh has joined affiliates of Apollo (NYSE: APO) and GeneSuites on the project, according to a statement.

“Innovation in biotechnology is rapidly evolving to push the possibilities of advanced therapies, but the shortage of manufacturing capacity has resulted in delayed timelines and higher costs,” said Gary Schoenhouse, GeneSuites’ Chief Technical Advisor. “Catalyst BioCampus’ High-Performance Shell advances building shell infrastructure while providing optimal flexibility to enhance biopharmaceutical companies’ treatment timelines.”

The facility, once built, will provide 446,000 square feet of manufacturing, lab, and office space and will be located alongside the FUJIFILM Diosynth Biotechnologies and Seqirus campuses, all of which are adjacent to a planned mixed-use retail and hospitality destination opening in 2023.

$2B Fujifilm Diosynth Biotechnologies plant moves closer to reality in Holly Springs

Holly Springs attracted 40% of Triangle’s life science investment since 2018

“The pandemic has heightened awareness of the value of speed and safety in bringing new biological innovations to market, and we’re fortunate to have this unique resource in the Town of Holly Springs to support the Town’s growing presence as a global biomanufacturing leader,” said Bill Bullock, SVP of Economic Development with North Carolina Biotechnology Center.

Since 2018, over 40% of the $6.4 billion of life sciences manufacturing investment in Raleigh-Durham has landed in Holly Springs, according to CBRE.

“Holly Springs is quickly becoming a go-to hub for life sciences in North Carolina given its location, amenities, and population base. We are excited to deliver real estate we believe to be mission-critical to support the crucial advancement of biomanufacturing in the 21st century,” said Apollo’s Poojan Mehta.

In addition to FUJIFILM Diosynth Biotechnologies, which is building a $2 billion facility, and Seqirus, which invested an additional $156 million bringing total investment to $1.2 billion, Amgen recently broke ground on its new $550 million biomanufacturing facility in Holly Springs.

Catalyst BioCampus is currently under construction and will be delivered in early 2023, according to CBRE|Raleigh.

Amgen expects new Holly Springs plant to be ‘a permanent home’

The post Meet Catalyst BioCampus, the latest life science development in Holly Springs first appeared on WRAL TechWire.

manufacturing
biopharmaceutical
life sciences